Patricia van Dijck
Public Communications Contact chez GSK Belux
Profil
Patricia van Dijck is currently the Director-Market Access & Public Affairs at GSK Belux since 2018.
Prior to this, she worked as an Independent Director at Mithra Pharmaceuticals SA from 2021 to 2023, as a Medical Director at Lundbeck SA from 1998 to 2007, and as the Head-Market Access & Public Affairs at Novartis Belux.
She holds a doctorate degree from the Université Catholique de Louvain.
Postes actifs de Patricia van Dijck
| Sociétés | Poste | Début |
|---|---|---|
| GSK Belux | Public Communications Contact | 01/01/2018 |
Anciens postes connus de Patricia van Dijck
| Sociétés | Poste | Fin |
|---|---|---|
| MITHRA PHARMACEUTICALS S.A. | Chairman | 01/06/2021 |
| Novartis Belux | Public Communications Contact | - |
Lundbeck SA
 Lundbeck SA Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck SA is a Belgian company founded in 2000. The private company is based in Brussels, Belgium. The company's description mentions that a migraine attack is a severe headache, usually present with other symptoms, that stops a person from going about their daily life. | Chief Executive Officer | - |
Formation de Patricia van Dijck
| Université Catholique de Louvain | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MITHRA PHARMACEUTICALS S.A. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Lundbeck SA
Lundbeck SA Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck SA is a Belgian company founded in 2000. The private company is based in Brussels, Belgium. The company's description mentions that a migraine attack is a severe headache, usually present with other symptoms, that stops a person from going about their daily life. | Health Technology |
| Novartis Belux | |
| GSK Belux |
